LACK OF APPLICATION SITE ROTATION

This adverse event was reported 151 times

These drugs are most commonly taken by patients reporting LACK OF APPLICATION SITE ROTATION:

# Drug Count
0 NORELGESTROMIN AND ETHINYL ESTRADIOL 21
1 BUPRENORPHINE 11
2 DUPILUMAB 8
3 RIVASTIGMINE 8
4 PANTOPRAZOLE 7
5 AMLODIPINE BESYLATE 6
6 LEVOTHYROXINE SODIUM 6
7 PREGABALIN 6
8 SOMATROPIN 6
9 ASPIRIN 5
See all common drugs associated with LACK OF APPLICATION SITE ROTATION

LACK OF APPLICATION SITE ROTATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NORELGESTROMIN AND ETHINYL ESTRADIOL 21 0.0113
1 DICLOXACILLIN SODIUM 1 0.0011
2 SOLIFENACIN SUCCIATE 1 0.0005
3 LANREOTIDE ACETATE 4 0.0005
4 RIVASTIGMINE 8 0.0004
5 ROTIGOTINE 5 0.0003
6 SELEGILINE 1 0.0003
7 GRANISETRON HYDROCHLORIDE 3 0.0003
8 GRANISETRON 3 0.0003
9 SCOPOLAMINE 1 0.0003
See all drugs enriched for association with LACK OF APPLICATION SITE ROTATION

LACK OF APPLICATION SITE ROTATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cholinesterase Inhibitor [EPC] 8 0.0004
1 Monoamine Oxidase Inhibitor [EPC] 1 0.0003
2 Nonergot Dopamine Agonist [EPC] 5 0.0003
3 Ergot Derivative [EPC] 1 0.0002
4 Estrogen [EPC] 26 0.0001
5 Provitamin D2 Compound [EPC] 4 0.0001
6 Partial Opioid Agonist [EPC] 11 0.0001
7 Recombinant Human Growth Hormone [EPC] 2 0.0001
8 PCSK9 Inhibitor [EPC] 2 0.0001
9 Progestin [EPC] 21 0.0001
See all drug classes enriched for association with LACK OF APPLICATION SITE ROTATION